This £250K study funded by CRUK is being undertaken at 6 sites across the UK and will complete in February 2015.
80 postmenopausal women with ER positive breast cancer will be recruited into a surgical window study assessing the effect of an Aromatase Inhibitor comparing FLT PET activity with a histological measure Ki67.
A feasibility study is being carried out to look at delivery of FLT across sites, the quality of the FLT data being acquired with dynamic scans being carried out at two sites.
People specializing in this area
Charlotte Daniels
